Purpose: To examine differences in effects according to growth hormone (GH) treatment duration in adult GH-deficient patients. Methods: In the Italian cohort of the observational Hypopituitary Control and Complications Study, GH-treated adults with GH deficiency (GHD) were grouped by duration of treatment; ≤ 2 years (n = 451), > 2 to ≤ 6 years...
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2017 (v1)Publication
Purpose: To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope®, a somatropin biosimilar to Genotropin®, in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults study. Methods: The PATRO Adults study is an ongoing observational, longitudinal, non-interventional global...
Uploaded on: April 14, 2023